DUBLIN, Sept. 6, 2021 /PRNewswire/ — The «Chemotherapy Induced Anemia – Drugs In Development, 2021» report has been added to ResearchAndMarkets.com’s offering.
The pipeline guide provides comprehensive information on the therapeutics under development for Chemotherapy Induced Anemia (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 2, 2, 1, 5 and 1 respectively.
The pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Anemia (Toxicology).
- The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Anemia (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chemotherapy Induced Anemia (Toxicology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chemotherapy Induced Anemia (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Anemia (Toxicology)
Key Topics Covered:
- Chemotherapy Induced Anemia – Overview
- Pipeline Overview
- Chemotherapy Induced Anemia – Therapeutics Assessment
- Chemotherapy Induced Anemia – Companies Involved in Therapeutics Development
- Chemotherapy Induced Anemia – Drug Profiles
- Chemotherapy Induced Anemia – Dormant Projects
- Chemotherapy Induced Anemia – Discontinued Products
- Chemotherapy Induced Anemia – Product Development Milestones
- Featured News & Press Releases
- Avesthagen Ltd
- Cadila Healthcare Ltd
- FibroGen Inc
- General Biologics Inc
- Jecho Biopharmaceuticals Co Ltd
- Panacea Biotec Ltd
- PharmaEssentia Corp
- PhytoHealth Corp
- SBI Pharmaceuticals Co Ltd
- Sumitomo Dainippon Pharma Oncology, Inc
- Therapure Biopharma Inc
- UBI Pharma Inc
- Vifor Pharma Ltd
For more information about this report visit https://www.researchandmarkets.com/r/kgl8vu
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets